财经快讯|康弘药业:立他司特滴眼液正按既定研发计划推进,公司药材种植基地产出主要为自用
康弘药业7月19日在互动平台表示,公司将继续集中资源,不断加强完善具有康弘特色的产品布局,并持续在眼科、脑科、肿瘤等领域加大投入、深入研究、专业创新,不断推出高品质新产品。立他司特滴眼液目前正按既定研发计划推进,公司将会严格恪守真实、准确、完整、及时、公平原则对相关情况予以披露。截至目前,公司的药材种植基地产出的中药材主要为自用。
Statement:
The content of this article does not represent the views of fxgecko website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!